organocatalysis - enamine catalysis - aminocatalysis - peptides
Enantioselective organocatalysis with amines, also termed asymmetric aminocatalysis, is a useful strategy for several important carbonyl reactions.
[2 ]
Among the catalysts studied so far, the amino acid proline has arguably been the most successful in enamine involving reactions.
[3-6 ]
Its popularity is based on the efficiency and stereoselectivity often encountered in proline-catalyzed reactions and on its inexpensive and non-toxic nature. Despite these attractive features, there is still room for improvement. For example, potentially useful donors such as acetaldehyde
[7 ]
and acetophenone
[8 ]
can not readily be used, stereoselectivities and yields can be sub-optimal, and α-unbranched aldehydes are notorious acceptors in proline-catalyzed aldol reactions.
[4c ]
In addition, there are several interesting enamine involving reactions that can not be catalyzed by proline. To address these shortcomings, a readily available and diversifiable substance-class from which improved enamine catalysts could be selected is highly desirable. Here we show for the first time that N- terminal prolyl-peptides efficiently catalyze asymmetric aldol and Michael reactions.
Pioneered by Miller
[9 ]
and Jacobsen
[10 ]
catalytic peptides and peptide-like molecules were recently introduced as asymmetrc catalysts.
[11 ]
Their structural and chemical diversity, accessibility, and inherent chirality could make them ideal asymmetric organocatalysts for a variety of reactions. We speculated that the infinite sequence space of N -terminal prolyl peptides might be a good source for the discovery of novel enamine catalysts. To test this hypothesis we have studied di- and tripeptide-catalyzed aldol reactions of acetone with p- nitrobenzaldehyde. To our delight, we found all tested peptides to show efficient catalytic activity producing the aldol product in good yields (62-90%) and enantioselectivities (31-77%, Table
[1 ]
). These results are particularly remarkable in light of the observation that catalysis by proline amide is much less efficient than that by proline, and that it provides the product in only 20% ee.
Next, we found the same peptides to also catalyze direct asymmetric Michael reactions between acetone and trans- β-nitrostyrene with good results (Table
[2 ]
). Here, enantioselectivities of up to 31% were observed. Though still modest, these enantioselectivities constitute a significant improvement over the 7% ee realized in the corresponding proline-catalyzed reaction.
Table 1 Peptide-Catalyzed Aldol Reactions
Entry
Catalyst
Yield (%)a
ee (%)b
1
Pro-OH
68
76
2
Pro-Ala
90
70
3
Pro-Trp
77
65
4
Pro-Asp
75
74
5
Pro-Glu
72
68
6
Pro-Val
89
70
7
Pro-Arg
91
31
8
Pro-Ser
87
77
9
Pro-Lys·HCl
62
66
10
Pro-Gly-Gly
68
53
11
Pro-His-Ala
85
56
a Yields were determined by preparative TLC. As the major side product the aldol condensation product has been identified.
b Enantiomeric excess (ee) values were determined from chiral stationary-phase HPLC analysis.
Table 2 Peptide-Catalyzed Michael Reactions
Entry
Catalyst
Yield (%)a
ee (%)b
1
Pro-OH
97
7
2
Pro-Ala
71
5
3
Pro-Trp
68
0
4
Pro-Asp
75
3
5
Pro-Glu
91
8
6
Pro-Val
65
31
7
Pro-Arg
65
19
8
Pro-Ser
81
8
9
Pro-Lys·HCl
66
8
10
Pro-Gly-Gly
79
10
11
Pro-His-Ala
70
7
a Yields were determined by preparative TLC. No side products have been identified.
b Enantiomeric excess (ee) values were determined from chiral stationary-phase HPLC analysis.
In conclusion we show that N- terminal prolyl peptides are promising asymmetric aminocatalysts. Although only modest enhancements compared to proline catalysis were realized so far, our results suggest that screening larger libraries of N- terminal prolyl peptides could provide effective catalysts with improved enantioselectivities and yields.
[12 ]
In addition we expect N- terminal prolyl peptides to become useful catalysts for a variety of other important aminocatalytic transformations.
Acknowledgment Support by the NIH (GM-63914) is gratefully acknowledged. We thank William T. Biller for technical assistance.